AI-designed mRNA vaccine formulations hold up at 37 °C for more than 2 months
Solid-state mRNA vaccine formulations kept 100% of their bioactivity after more than 2 months at 37 °C, a study in Nature Biotechnology reports. Today's mRNA-lipid nanoparticle vaccines need ultra-cold storage. The team used an AI framework called AGENT, which reached the result in six iterations over 1 month. Tested in rodents and non-human primates, the dry doses drew immune responses non-inferior to freshly prepared soluble vaccines.
Ultra-cold storage limits how far mRNA vaccines can be distributed, and formulations that survive 37 °C go after that constraint directly.
Source: Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI - Nature Biotechnology (nature.com).
Written by the HappyGood desk from the primary source linked above and checked against it. Every story links its source. Corrections: [email protected].
More from the archive
- Blind Herefordshire writer gains international acclaim for debut short film Blind Faith October 18, 2026
- At 91, Barrie man stays active every day at East Bayfield Community Centre October 18, 2026
- Wrexham care home residents take nostalgic train ride through Dee Valley October 17, 2026
- Roslin pupils sow wildflower meadow by hand at Roslin Glen October 16, 2026
- Oyster sanctuary network in North Carolina's Pamlico Sound reaches 500-acre goal October 16, 2026